Literature DB >> 19740630

Signs of striatal dopamine transporter density increase in association with improvement of tardive dyskinesia in a patient with schizophrenia, as demonstrated by a DAT scan.

E N Rizos1, S Chatziioannou, A Douzenis, N Siafakas, E Katsantoni, P Nikolaidou, M Papathanasiou, L Lykouras.   

Abstract

The imaging of the dopamine transporter could demonstrate the implication of dopaminergic pathway in the appearance of tardive dyskinesia. We report a case with psychotic and tardive dyskinesia symptoms. A DAT scan showed decreased dopamine transporter uptake in the area of brain's basal gaglia. A trial with quetiapine improved both psychotic and TD symptoms while a second DAT scan showed improvement status. We conclude that increased dopamine transporter uptake seemed to associate with the improvement of TD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740630     DOI: 10.1016/j.euroneuro.2009.08.002

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  2 in total

1.  ECT in a patient with Parkinson's disease and schizophrenia, with dopamine transporter visualisation using 123I-ioflupane SPET.

Authors:  Paloma Fernández-Corcuera; Salvatore Aguilar; Víctor Viçens; Jaume Mora; Ana Benitez; Amparo García-Burillo; Edith Pomarol-Clotet; Peter McKenna
Journal:  J Neural Transm (Vienna)       Date:  2011-02-27       Impact factor: 3.575

2.  Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations.

Authors:  Jungjin Kim; Eric Macmaster; Thomas L Schwartz
Journal:  Drugs Context       Date:  2014-04-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.